← Evidence map

ArticleInflammation2014

Higher percentage of CD3⁺CD154⁺ T lymphocytes predicts efficacy of TNF-α inhibitors in active axial SpA patients.

Zhiming Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2014

2015

2016

2017

this papercites it

Higher percentage of CD3⁺CD154⁺ T lymphocytes predicts efficacy of TNF-α inhibitors in active axial SpA patients. | OpenQuestion